| 摘要 |
The disclosure is of a combination of lactic acid bacteria comprising: (a) a first component consisting of at least one strain of H<SUB>2</SUB>O<SUB>2</SUB>-producing lactic acid bacteria; and (b) a second component consisting of at least one strain of arginine-utilizing lactic acid bacteria. The disclosure is also of the use of this combination for making a food supplement, a hygiene product or a pharmaceutical preparation for the prevention and/or treatment of infections and inflammatory conditions caused by bacteria, viruses or fungi, especially in the mouth, vagina, urethra, nose, eyes and ears. |
